Qiaozhen Su

427 total citations · 1 hit paper
9 papers, 272 citations indexed

About

Qiaozhen Su is a scholar working on Complementary and alternative medicine, Neurology and Molecular Biology. According to data from OpenAlex, Qiaozhen Su has authored 9 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Complementary and alternative medicine, 4 papers in Neurology and 3 papers in Molecular Biology. Recurrent topics in Qiaozhen Su's work include Ginkgo biloba and Cashew Applications (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Dysphagia Assessment and Management (2 papers). Qiaozhen Su is often cited by papers focused on Ginkgo biloba and Cashew Applications (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Dysphagia Assessment and Management (2 papers). Qiaozhen Su collaborates with scholars based in China, Australia and United States. Qiaozhen Su's co-authors include Hongfeng Liang, Chang An, Yan Zeng, Zhuo Li, Zhe Li, Xiaodong Luo, Weidong Li, Lei Ma, Dandan Ma and Qian Wang and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Frontiers in Immunology and Frontiers in Pharmacology.

In The Last Decade

Qiaozhen Su

8 papers receiving 268 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut bacterial profiles in Parkinson's disease: A systematic review

2022 132 citations Zhe Li, Hongfeng Liang et al. CNS Neuroscience & Therapeutics profile →

Peers

Countries citing papers authored by Qiaozhen Su

Since Specialization

Citations

This map shows the geographic impact of Qiaozhen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiaozhen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiaozhen Su more than expected).

Fields of papers citing papers by Qiaozhen Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiaozhen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiaozhen Su. The network helps show where Qiaozhen Su may publish in the future.

Co-authorship network of co-authors of Qiaozhen Su

This figure shows the co-authorship network connecting the top 25 collaborators of Qiaozhen Su. A scholar is included among the top collaborators of Qiaozhen Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiaozhen Su. Qiaozhen Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Case Reports: Three cases of autoimmune glial fibrillary acidic protein astrocytosis in disguise 2025 ·Frontiers in Immunology ·(unknown), L H Gong, (unknown), Zhiguang Chen, Zhe Li, Qiaozhen Su, Yang Shen, (unknown)	0
2	Real-world Chinese herbal medicine for Parkinson's disease: a hospital-based retrospective analysis of electronic medical records 2024 ·Frontiers in Aging Neuroscience ·(unknown), Claire Shuiqing Zhang, (unknown), Xinfeng Guo, Zhe Li, Xiaodong Luo, (unknown), Qiaozhen Su	1
3	Real-world observations and impacts of Chinese herbal medicine for migraine: results of a registry-based cohort study 2024 ·Frontiers in Pharmacology ·(unknown), Claire Shuiqing Zhang, Anthony Lin Zhang, Xinfeng Guo, (unknown), (unknown), Qiaozhen Su, Charlie Changli Xue, (unknown)	1
4	Gut bacterial profiles in Parkinson's disease: A systematic review breakdown → 2022 ·CNS Neuroscience & Therapeutics ·Zhe Li, Hongfeng Liang, (unknown), (unknown), (unknown), (unknown), Bin Wu, (unknown), Xiaodong Luo, (unknown), Yan Zeng, Ziyan Liu, (unknown), Zhenyu Yue, Yi Ren, Zhuo Li, Qiaozhen Su, Pingyi Xu	132
5	Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson’s Disease 2021 ·Frontiers in Immunology ·Zhuo Li, Gang Lü, Zhe Li, Bin Wu, (unknown), Xinmin Qiu, Jianwen Guo, Zhangyong Xia, (unknown), Qiaozhen Su, Yan Zeng, Wai‐Yee Chan, Xianwei Su, (unknown), Yanjuan Xu, Yingjun Chen, Mingbang Wang, Wai Sang Poon, Xiaodong Luo	48
6	Rules of Meridians and Acupoints Selection in Treatment of Parkinson's Disease Based on Data Mining Techniques 2018 ·Chinese Journal of Integrative Medicine ·Zhe Li, (unknown), (unknown), Qiaozhen Su, Chang An, Xiao‐Dong Luo, (unknown)	16
7	Mitochondria-Associated Apoptosis in Human Melanoma Cells Induced by Cardanol Monoene from Cashew Nut Shell Liquid 2017 ·Journal of Agricultural and Food Chemistry ·(unknown), Yu‐Feng Lin, (unknown), Yuxia Wang, Xiaodong Lin, Qiaozhen Su, Dong‐Yan Shen, (unknown)	16
8	[Pathogenesis of Parkinson's Disease Viewing from Modern Chinese Medicine]. 2016 ·PubMed ·Qiaozhen Su, Hongfeng Liang, Chang An, Zhe Li, Xiaodong Luo	1
9	Honokiol Suppresses Renal Cancer Cells’ Metastasis via Dual-Blocking Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties through Modulating miR-141/ZEB2 Signaling 2014 ·Molecules and Cells ·Weidong Li, Qian Wang, Qiaozhen Su, Dandan Ma, Chang An, Lei Ma, Hongfeng Liang	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact